Leveraging Real-world Insights to Inform Patient-Centered Care: Modern JAKi Strategies in Individualized Myelofibrosis Management

Learn more about leading experts’ practical approaches to optimizing JAK inhibitor therapy for patients with myelofibrosis and gain valuable insights to enhance your patients’ outcomes by tailoring treatments to meet individual needs in myelofibrosis care.

Share

Program Content

Activities

JAKi Strategies for MF
Modern JAKi Strategies in Individualized Myelofibrosis Management: Insights from Community Oncologists Following Participation in Collaborative Learning Workshops
PDF
Congratulations: You achieved a completion on 04/09/2022

Released: November 11, 2024

Expires: November 10, 2025

Provided by

ProCE Banner

Provided by Clinical Care Options, LLC.

Supporters

Supported by educational grants from CTI BioPharma Corp., a Sobi Company; and Incyte Corporation.

CTI BioPharma Corp., a Sobi Company

Incyte Corporation